Application 084937
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMIPRAMINE HYDROCHLORIDE | IMIPRAMINE HYDROCHLORIDE | TABLET;ORAL | 50MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-1766 | Imipramine Hydrochloride | Imipramine Hydrochloride | Sandoz Inc | ANDA | Current |
| 0781-1766 | Imipramine Hydrochloride | Imipramine Hydrochloride | Sandoz Inc | ANDA | Current |
| 0781-1766 | Imipramine Hydrochloride | Imipramine Hydrochloride | Sandoz Inc | ANDA | Current |
| 51655-455 | IMIPRAMINE HYDROCHLORIDE | IMIPRAMINE HYDROCHLORIDE | Northwind Pharmaceuticals, LLC | ANDA | Current |